 |
 |

Surface Microscopy of Pigmented Basal Cell Carcinoma
Scott W. Menzies, MB, BS, PhD;
Karin Westerhoff, MD;
Harold Rabinovitz, MD;
Alfred W. Kopf, MD;
William H. McCarthy, MBBS, MEd;
Brian Katz
Arch Dermatol. 2000;136:1012-1016.
Objectives To describe the relevant morphologic features and to create a simple diagnostic method for pigmented basal cell carcinoma (BCC) using in vivo cutaneous surface microscopy (ie, dermoscopy, dermatoscopy, or oil epiluminescence microscopy).
Design Pigmented skin lesions were photographed in vivo using immersion oil (surface microscopy). All pigmented skin lesions were excised and reviewed for histological diagnosis. Photographs of 142 pigmented BCCs, 142 invasive melanomas, and 142 benign pigmented skin lesions were randomly divided into 2 equally sized training and test sets. Images from the training set were scored for 45 surface microscopy features. From this a model was derived and tested on the independent test set.
Setting All patients were recruited from the primary case and referral centers of the Sydney Melanoma Unit, Sydney, Australia, and the Skin and Cancer Unit, Skin and Cancer Associates, Plantation, Fla.
Patients A random sample (selected from a larger database) of patients whose lesions were excised.
Main Outcome Measures Sensitivity and specificity of the model for diagnosis of pigmented BCCs.
Results The following model was created. For a pigmented BCC to be diagnosed it must not have the negative feature of a pigment network and must have 1 or more of the following 6 positive features: large gray-blue ovoid nests, multiple gray-blue globules, maple leaflike areas, spoke wheel areas, ulceration, and arborizing "treelike" telangiectasia. On an independent test set the model had a sensitivity of 97% for the diagnosis of pigmented BCCs and a specificity of 93% for the invasive melanoma set and 92% for the benign pigmented skin lesion set.
Conclusion A robust surface microscopy method is described that allows the diagnosis of pigmented BCCs from invasive melanomas and benign pigmented skin lesions.
From the Sydney Melanoma Unit, Melanoma and Skin Cancer Research Institute, Department of Surgery, University of Sydney, Sydney, Australia (Drs Menzies, Westerhoff, and McCarthy); Skin and Cancer Associates and the Department of Dermatology, School of Medicine, University of Miami, Miami, Fla (Dr Rabinovitz and Mr Katz); and the Ronald O. Perelman Department of Dermatology, New York University Medical Center, New York (Dr Kopf). The authors have no commerical, proprietary, or financial interests in the products and companies described in this article.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Dermoscopic Evaluation of Amelanotic and Hypomelanotic Melanoma
Menzies et al.
Arch Dermatol 2008;144:1120-1127.
ABSTRACT
| FULL TEXT
Dermoscopy and the Diagnostic Challenge of Amelanotic and Hypomelanotic Melanoma
Stoecker and Stolz
Arch Dermatol 2008;144:1207-1210.
FULL TEXT
The Dragon With Atypical Mole Syndrome
Kluger and Thomas
Arch Dermatol 2008;144:948-949.
FULL TEXT
Dermoscopy of Solitary Angiokeratomas: A Morphological Study
Zaballos et al.
Arch Dermatol 2007;143:318-325.
ABSTRACT
| FULL TEXT
Dermoscopy patterns of fibroepithelioma of pinkus.
Zalaudek et al.
Arch Dermatol 2006;142:1318-1322.
ABSTRACT
| FULL TEXT
Vascular Structures in Skin Tumors: A Dermoscopy Study
Argenziano et al.
Arch Dermatol 2004;140:1485-1489.
ABSTRACT
| FULL TEXT
Clonal Seborrheic Keratosis: A Dermoscopic Pitfall
Zalaudek et al.
Arch Dermatol 2004;140:1169-1170.
FULL TEXT
Dermatoscopy Turns Histopathologist's Attention to the Suspicious Area in Melanocytic Lesions
Bauer et al.
Arch Dermatol 2001;137:1338-1340.
ABSTRACT
| FULL TEXT
Epiluminescence for Pigmented Basal Cell Carcinoma
Journal Watch Dermatology 2000;2000:3-3.
FULL TEXT
|